RotationRx · Drugs · Scores · Protocols · Diagnoses · Specialties

← Diagnosis and Management Guides

Chronic Kidney Disease Management

Key considerations: Rapidly progressive GN, Reversible causes of CKD decline, Uremic emergency

Cannot miss

  • Rapidly progressive GN
  • Reversible causes of CKD decline
  • Uremic emergency

Likely diagnoses

  • Diabetic nephropathy
  • Hypertensive nephrosclerosis
  • Glomerulonephritis
  • PCKD
  • Obstructive uropathy

Red flags

  • Rapid GFR decline (>5mL/min/year)
  • Refractory hyperkalemia
  • Severe metabolic acidosis
  • Uremic symptoms (pericarditis, encephalopathy, bleeding)

Workup

  • history: Etiology, medication review, symptoms of uremia, volume status; exam: Blood pressure, volume status, peripheral edema; labs: BMP, CBC, phosphorus, calcium, PTH, albumin, lipids, HbA1c, UACR; imaging: Renal ultrasound at diagnosis; bedside: Blood pressure measurement

Management

  • immediate: Stage 4-5: nephrology referral, dialysis access planning; general: ACEi/ARB for proteinuria and BP control; SGLT2 inhibitor (dapagliflozin, empagliflozin) — slows CKD progression; BP target <130/80; Statin for cardiovascular risk; Phosphate binders, vitamin D, EPO as needed; Avoid nephrotoxins (NSAIDs, contrast, aminoglycosides); Medication dose adjustments

Disposition

  • admit: Uremic emergency, severe electrolyte derangements, need for urgent dialysis; discharge: Stable CKD with nephrology co-management; consults: Nephrology for Stage 4+, vascular surgery for access planning

Clinical pearls

  • SGLT2 inhibitors reduce CKD progression by 30-40% regardless of diabetes status — game-changing
  • Metabolic acidosis in CKD: sodium bicarbonate supplementation slows GFR decline
  • Avoid NSAIDs, minimize contrast exposure, and dose-adjust all renally cleared medications

Source and review

  • KDIGO CKD Guidelines 2024. Last reviewed: 2024-11-01